Cadila Pharmaceuticals is an Indian pharmaceutical company which was founded in 1951 with a mission to provide affordable healthcare for people.
The company was founded by Mr Indravadan A Modi and is headquartered in Ahmedabad in the state of Gujarat. Cadila sells as well as manufactures Active Pharmaceutical Ingredients (APIs) and finished Formulations in over 80 countries around the globe.
In 1995, the company was restructured into 2 separate companies namely Cadila Healthcare and Cadila Pharmaceuticals.
The company offers formulations in the therapeutic areas like cardiovascular, analgesics, anti-infectives, antibiotics, respiratory agents and antidiabetics.
Cadila believes in strong scientific collaborations with world class institutions to develop medical treatments for unmet needs. In 2013 they joined hands with Helperby for antibiotic drug research and development. The company has a very large production facilities located at Dholka in Gujarat, Samba, Jammu and at Addis Ababa in Ethiopia.
It is the first company to get ND (New Drug) approvals for clinical trials to be conducted in India. The company has well established R&D facility at Dholka in Gujarat and it spends high on its research of new drugs and formulations. The company spend almost 640 crores in its R&D this financial year. The company is also first to introduce Rabeloc in the world. It is the only Indian manufacturer which manufactures Hyaluronic and Streptokinase products.
Cadila also offers Contract Manufacturing and Contract Research in the services segment. Cadila produces many brands which also includes some of the champion brands like Polycap, Risorine and Aciloc which mainly cures heart diseases and Tuberculosis.\